Drugs / Lactobacillus plantarum
Lactobacillus plantarum
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT06863194 | Apr → Oct 2025 overdue | chronic kidney disease, uremia | Mansoura University | Recruiting | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT07194200 | Dec 2025 → Jun 2026 overdue | psoriasis | Shenzhen People's Hospital | Recruiting | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03885973 | Jul → Aug 2018 | constipation disorder | Faculty of Medicine, University of Indonesia | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT04639141 | Dec 2021 → Apr 2022 | anxiety, autism spectrum disorder | The University of Queensland | Completed | No outcome recorded |
| — | NCT03350893 | Sep 2017 → Jul 2018 | skin disorder | GenMont Biotech Incorporation | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus plantarum | “In this clinical study, the investigators researched the benefit effects of heat-killed Lactobacillus plantarum cream on skin health.” NCT03350893 ↗ |
| Known as | IS 10560 | “Lactobacillus Plantarum IS 10560 Supplementation in Women With Functional Constipation” NCT03885973 ↗ |
| Known as | IS-10506 | “containing probiotic Lactobacillus plantarum IS-10506” NCT03885973 ↗ |
| Known as | L. plantarum | “Potassium Hydroxide, Heat-killed L. plantarum powders” NCT03350893 ↗ |
| Modality | Other / unclassified | “Prebiotic + Probiotic” NCT04639141 ↗ |
| Route | Topical | “To evaluate the efficacy of applying probiotic cream in the ameliorationof the whole face skin conditions” NCT03350893 ↗ |